Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

CORR Insights®

Neoadjuvant Chemotherapy Followed by Delayed Surgery

Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?

Miller, Benjamin J., MD, MS

Clinical Orthopaedics and Related Research®: November 2018 - Volume 476 - Issue 11 - p 2187–2189
doi: 10.1097/CORR.0000000000000473
CLINICAL RESEARCH

B. J. Miller, University of Iowa, Department of Orthopaedics and Rehabilitation, Iowa City, IA, USA

Benjamin J. Miller MD, MS, University of Iowa, Department of Orthopaedics and Rehabilitation, 200 Hawkins Drive, 01015 JPP, Iowa City, IA 52242, USA, Email: benjamin-j-miller@uiowa.edu

This CORR Insights® is a commentary on the article “Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?” by Xu and colleagues available at: DOI: 10.1097/CORR.0000000000000387.

The author certifies that neither he, nor any members of his immediate family, have any commercial associations (such as consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article.

All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research® editors and board members are on file with the publication and can be viewed on request.

The opinions expressed are those of the writers, and do not reflect the opinion or policy of CORR® or The Association of Bone and Joint Surgeons®.

This CORR Insights® comment refers to the article available at DOI: 10.1097/CORR.0000000000000387.

Received July 23, 2018

Accepted August 08, 2018

© 2018 Lippincott Williams & Wilkins LWW
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website